Biological response of hepatomas to an extract of fagopyrum esculentum M. (Buckwheat) is not mediated by inositols or rutin

Journal of Agricultural and Food Chemistry

Volumn 58, Issue 5, 2010, Pages 3197-3204

  Curran, Julianne M ^a   Stringer, Danielle M ^a,b   Wright, Brenda ^b   Taylor, Carla G ^a,b   Przybylski, Roman ^c   Zahra, Peter ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b The Inst of Cardiovascular Sciences   (Canada)

^c UNIVERSITY OF LETHBRIDGE   (Canada)

Author keywords

Buckwheat; Diabetes; Fagopyrum esculentum m; Glucose uptake; Inositols; P42 44 erk; Rutin

Indexed keywords

INOSITOL; PLANT EXTRACT; RUTOSIDE;

ANIMAL; ARTICLE; CHEMISTRY; ENZYMOLOGY; FAGOPYRUM; LIVER TUMOR; PATHOLOGY; RAT;

ANIMALS; FAGOPYRUM; INOSITOL; LIVER NEOPLASMS, EXPERIMENTAL; PLANT EXTRACTS; RATS; RUTIN;

FAGOPYRUM ESCULENTUM; RATTUS;

EID: 77949356559     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf903890c     Document Type: Article

References (32)

1. Kanzaki, M.; Pessin, J. E. Signal integration and the specificity of insulin action. Cell Biochem. Biophys. 2001, 35, 191-209.
2. Wahren, J.; Ekberg, K. Splanchnic regulation of glucose production. Annu. Rev. Nutr. 2007, 27, 329-345.
3. Horbowicz, M.; Obendorf, R. L. Seed desiccation tolerance and storability: dependence on flatulence-producing oligosaccharides and cyclitols - review and survey. Seed Sci. Res. 1994, 4, 385-405.
4. Lamer, J.; Huang, L. C.; Schwartz, C. F.; Oswald, A. S.; Shen, T. Y.; Kinter, M.; Tang, G. Z.; Zeller, K. Rat liver insulin mediator which stimulates pyruvate dehydrogenase phosphate contains galactosamine and D-chiroinositol. Biochem. Biophys. Res. Commun. 1988, 151, 1416-1426.
5. Field, M. C. Is there evidence for phospho-oligosaccharides as insulin mediators? Glycobiology 1997, 7, 161-168.
6. Jones, D. R.; Varela-Nieto, I. The role of glycosyl-phosphatidylinositol in signal transduction. Int. J. Biochem. Cell Biol. 1998, 30, 313-326.
7. Jones, D. R.; Varela-Nieto, I. Diabetes and the role of inositol-containing lipids in insulin signaling. Mol. Med. 1999, 5, 505-514.
8. Fonteles, M. C.; Almeida, M. Q.; Lamer, J. Antihyperglycemic effects of 3-O-methyl-D-chiro-inositol and D-chiro-inositol associated with manganese in streptozotocin diabetic rats. Horm. Metab. Res. 2000, 32, 129-132.
9. Ortmeyer, H. K.; Bodkin, N. L.; Lilley, K.; Lamer, J.; Hansen, B. C. Chiroinositol deficiency and insulin resistance. I. Urinary excretion rate of chiroinositol is directly associated with insulin resistance in spontaneously diabetic rhesus monkeys. Endocrinology 1993, 132, 640-645.
10. Kawa, J. M.; Taylor, C. G.; Przybylski, R. Buckwheat concentrate reduces serum glucose in streptozotocin-diabetic rats. J. Agric. Food Chem. 2003, 51, 7287-7291.
11. Zhang, H. W.; Zhang, Y. H.; Lu, M. J.; Tong, W. J.; Cao, G. W. Comparison of hypertension, dyslipidaemia and hyperglycaemia between buckwheat seed-consuming and non-consuming MongolianChinese populations in Inner Mongolia, China. Clin. Exp. Pharmacol. Physiol. 2001, 34, 838-844.
12. Lu, C.; Zu, J.; Zho, P.; Ma, H.; Tong, H.; Jin, Y.; Li, S. Clinical application and therapeutic effect of composite tartary buckwheat flour on hyperglycemia and hyperlipidemia. In Proceedings of the 5th International Symposium on Buckwheat; Lin, R., Zhou, M., Tao, Y., Li, J., Zhang, Z., Eds.; Agriculture Publishing House: Beijing, China, 1992; pp 458-464.
13. Wang, J.; Liu, Z.; Fu, X.; Run, M. A clinical observation on the hypoglycemic effect of Xinjang buckwheat. In Proceedings of the 5th International Symposium on Buckwheat; Lin, R., Zhou, M., Tao, Y., Li, J., Zhang, Z., Eds.; Agriculture Publishing House: Beijing, China, 1992; pp 465-467.
14. Dickens, M.; Svitek, C. A.; Culbert, A. A.; O'Brien, R. M.; Tavare, J. M. Central role for phosphatidylinositide 3-kinase in the repression of glucose-6-phosphatase gene transcription by insulin. J. Biol. Chem. 1998, 273, 20144-20149.
15. Sharfi, H.; Eldar-Finkelman, H. Sequential phosphorylation of insulin receptor substrate-2 by glycogen synthase kinase-3 and c-Jun NH2-terminal kinase plays a role in hepatic insulin signaling. Am. J. Physiol. Endocrinol. Metab. 2008, 294, E307-E315.
16. Yau, L.; Elliot, T.; Lalonde, C.; Zahradka, P. Repression of phosphoenolpyruvate carboxykinase gene activity by insulin is blocked by 3-aminobenzamide but not by PD128763, a selective inhibitor of poly(ADP-ribose) polymerase. Eur. J. Biochem. 1998, 253, 91-100.
17. Yau, L.; Zahradka, P. Immunodetection of activated mitogenactivated protein kinase in vascular tissues. Mol. Cell. Biochem. 1997, 172, 59-66.
18. Yau, L.; Lukes, H.; McDiarmid, H.; Werner, J.; Zahradka, P. Insulin-like growth factor-I (IGF-I)-dependent activation of pp42/44 mitogen-activated protein kinase occurs independently of IGF-I receptor kinase activation and IRS-1 tyrosine phosphorylation. Eur. J. Biochem. 1999, 266, 1147-1157.
19. Harrison, S. A.; Buxton, J. M.; Helgerson, A. L.; MacDonald, R. G.; Chlapowski, F. J.; Carruthers, A.; Czech, M. P. Insulin action on activity and cell surface disposition of human HepG2 glucose transporters expressed in Chinese hamster ovary cells. J. Biol. Chem. 1990, 265, 5793-5801.
20. Hou, Z.; He, L.; Qi, R. Z. Regulation of s6 kinase 1 activation by phosphorylation at ser-411. J. Biol. Chem. 2007, 252, 6922-6928.
21. Asano, T.; Fujishiro, M.; Kushiyama, A.; Nakatsu, Y.; Yoneda, M.; Kamata, H.; Sakoda, H. Role of phosphatidylinositol 3-kinase activation on insulin action and its alteration in diabetic conditions. Biol. Pharm. Bull. 2007, 30, 1610-1616.
22. Cuenda, A.; Rousseau, S. p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim. Biophys. Acta 2007, 1773, 1358-1375.
23. Johnston, K.; Sharp, P.; Clifford, M.; Morgan, L. Dietary polyphenols decrease glucose uptake by human intestinal Caco-2 cells. FEBS Lett. 2005, 579, 1653-1657.
24. Srivastava, A. K.; Mehdi, M. Z. Insulino-mimetic and anti-diabetic effects of vanadium compounds. Diabetes Med. 2005, 22, 2-13.
25. Air, E. L.; Strowski, M. Z.; Benoit, S. C.; Conarello, S. L.; Salituro, G. M.; Guan, X. M.; Liu, K.; Woods, S. C.; Zhang, B. B. Small molecule insulin mimetics reduce food intake and body weight and prevent development of obesity. Nat. Med. 2002, 5, 179-183.
26. Jung, U. J.; Lee, M. K.; Jeong, K. S.; Choi, M. S. The hypoglycemic effects of hesperidin and naringin are partly mediated by hepatic glucose-regulating enzymes in C57BL/KsJ-db/db mice. J. Nutr. 2004, 134, 2499-2503.
27. Day, A. J.; Mellon, F.; Barron, D.; Sarrazin, G.; Morgan, M. R.; Williamson, G. Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin. Free Radical Res. 2001, 35, 941-952.
28. Erlund, I.; Kosonen, T.; Alfthan, G.; Maenpaa, J.; Perttunen, K.; Kenraali, J.; Parantainen, J.; Aro, A. Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers. Eur. J. Clin. Pharmacol. 2000, 56, 545-553.
29. Li, L.; Mellow, L.; Bhullar, R. P.; Fleming, N. Activation of phospholipase D by ADP-ribosylation factor in rat submandibular acinar cells. Arch. Oral Biol. 1998, 43, 211-219.
30. Morton, C.; Baines, R.; Masood, I.; Ng, L.; Boarder, M. R. Stimulation of two vascular smooth muscle-derived cell lines by angiotensin II: differential second messenger responses leading to mitogenesis. Br. J. Pharmacol. 1995, 115, 361-367.
31. Zahradka, P.; Litchie, B.; Storie, B.; Helwer, G. Transactivation of the insulin-like growth factor-I receptor by angiotensin II mediates downstream signaling from the angiotensin II type 1 receptor to phosphatidylinositol 3-kinase. Endocrinology 2004, 145, 2978-2987.
32. Saward, L.; Zahradka, P. Angiotensin II activates phosphatidylinositol 3-kinase in vascular smooth muscle cells. Circ. Res. 1997, 81, 249-257.